Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2025 / June / Also in the News…
Cornea Glaucoma Neuro-ophthalmology Pediatric Retina

Also in the News…

From EU approval for a pharmacological myopia treatment to startling disparities in cornea specialist coverage across the US, these are the news stories and studies that caught our attention this week…

6/13/2025 1 min read

Share

Tomwsulcer, CC0, via Wikimedia Commons

Cobra-D strike. Wasatch Photonics has announced the release of Cobra-D, an ultra-high resolution spectrometer for spectral domain optical coherence tomography (SD-OCT). The device can reportedly achieve imaging depths of up to 14mm by using 800nm light and CCD cameras. “Our expansion of the Cobra OCT spectrometer line with these new Cobra-D models is in direct response to a market need for cost-effective, high resolution 800 nm imaging in real time,” says company CEO, David Creasey. Link

EVER Congress. This year, the 28th annual EVER (European Association for Vision and Eye Research) Congress will be held in Florence, Italy on October 9-11 2025. The conference will cover topics including glaucoma, oncology, pediatric ophthalmology, neuro-ophthalmology, and lens disorders. EVER President Christina Zeitz said, “It is essential for EVER that these congress meetings are attended by delegates from all over the world,” especially young investigators, who have the opportunity to share their research and experience. Link

Slowing myopia in the EU. The European Commission (EC) has issued marketing authorization approval for Santen’s RYJUNEA®, the first pharmacological treatment approved to slow the progression of childhood myopia in the EU. “With this approval, ophthalmologists now have an evidence-based medication to help slow the progression of myopia”, notes Chief Medical Officer at Santen, Peter Sallstig.” Link

Major gaps in US cornea coverage. An American Journal of Ophthalmology study has revealed that 85.6 percent of US counties have no cornea specialist in their state. Researchers at the Department of Ophthalmology and Visual Science at Rutgers New Jersey Medical School assessed how cornea-specializing ophthalmologists are distributed across US counties and looked at the socioeconomic factors associated with their availability. Counties with at least one cornea ophthalmologist had significantly higher median incomes, education levels, health insurance coverage, and lower poverty rates, than those without such specialists. The authors recommend potential solutions, such as increasing residency slots in rural regions and expanding teleophthalmology to bridge these access gaps. Link

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: